The US API market is estimated to witness a growth rate of around 5.5% over the period of 2019–2025. Increasing prevalence of chronic and acute disease, growing focus on precision medicine, and surging biopharmaceutical industries in the country are some of the factors that are driving the US API market. Moreover, the presence of several pharmaceutical drug manufacturers in the country is also addressing the high demand for API. The manufacturers are focusing more on research to develop innovative pharmaceuticals drugs with the support of a research organization. The US spends more on healthcare as compared to any other sector. As per the Committee for a Responsible Federal Budget (CRFB), the US spent around $3.5 trillion on health expenditures. It is estimated to be 18% of GDP in 2017 as compared to approximately 17% in 2016. The US spent more than twice the average developed countries.

Visit for Global API Market Report at: https://www.omrglobal.com/industry-reports/api-market

The US API market is segmented on the basis of type, type of synthesis, manufacturer type, therapeutics, and region. On the basis of type, the market is divided into a generic API and branded API. The branded API segment is estimated to be the dominant segment over the forecast period. On the basis of the type of synthesis, the market is classified into biotech API, synthetic API, and others. The synthetic API segment held the dominant position in the US API market in 2018. Furthermore, the market is classified on the basis of therapeutics into cardiovascular drugs, oncology drugs, neurology drugs, Non-steroidal Anti-inflammatory Drugs (NSAIDs), and others. NSAIDs therapeutics segment held the leading position in 2018.

The US API market is fragmented in nature with the presence of various players operating in the market. Some of the prominent players that contribute significantly in the market include Teva Pharmaceutical Industries Ltd., Thermo Fisher Scientific Inc., Eli Lilly and Co., Lupin Pharmaceutical Inc., and others. These players operate in very highly competitive environment and thus adopts various strategies to stay competitive in the market. Mergers and acquisitions, new product launch, geographical expansion, manufacturing capability expansion are some of the majorly adopted strategies by these market players.

Research Methodology

The market study of the US API market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Authenticate databases such as the American Heart Association, the National Institute of Health, and the International Diabetes Federation.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report is intended for pharmaceutical and biotechnology companies, healthcare organizations, research institutes and academic institutes, pharmaceutical drug manufacturers, API manufacturers, raw material suppliers, distributors, traders, government organizations and regulatory agencies, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, different products, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation

1. US API Market Research and Analysis by Type
2. US API Market Research and Analysis by Type of Synthesis
3. US API Market Research and Analysis by Therapeutics

The Report Covers

• Comprehensive research methodology of Asia-Pacific API market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting Asia-Pacific API market.
• Insights about market determinants that are stimulating Asia-Pacific API market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.